Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.

Hwang, William L; Pleskow, Haley M; Miyamoto, David T

Hwang, William L; Pleskow, Haley M; Miyamoto, David T.

Afiliação

Hwang WL; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, United States; Massachusetts General Hospital Cancer Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
Pleskow HM; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, United States.
Miyamoto DT; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, United States; Massachusetts General Hospital Cancer Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address: dmiyamoto@mgh.harvard.edu.

Adv Drug Deliv Rev ; 125: 122-131, 2018 02 01.

Article em En | MEDLINE | ID: mdl-29326053

Assuntos

Biomarcadores Tumorais/análise; Neoplasias/patologia; Células Neoplásicas Circulantes/metabolismo; Células Neoplásicas Circulantes/patologia; Biomarcadores Tumorais/genética; Biomarcadores Tumorais/metabolismo; Humanos; Neoplasias/terapia

Palavras-chave

Cancer; Circulating tumor cells; Early cancer detection; Liquid biopsy; Precision therapy; Predictive biomarker; Prognostic biomarker; Tumor heterogeneity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Células Neoplásicas Circulantes / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google